124 related articles for article (PubMed ID: 9459204)
1. Translational research studies of erbB oncogenes: selection strategies for breast cancer treatment.
Brandt BH; Beckmann A; Gebhardt F; Rötger A; Jackisch C; Assmann G; Zänker KS
Cancer Lett; 1997 Oct; 118(2):143-51. PubMed ID: 9459204
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis.
Brandt B; Vogt U; Schlotter CM; Jackisch C; Werkmeister R; Thomas M; von Eiff M; Bosse U; Assmann G; Zänker KS
Gene; 1995 Jun; 159(1):35-42. PubMed ID: 7607571
[TBL] [Abstract][Full Text] [Related]
3. Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer.
Vogt U; Bielawski K; Schlotter CM; Bosse U; Falkiewicz B; Podhajska AJ
Gene; 1998 Nov; 223(1-2):375-80. PubMed ID: 9858771
[TBL] [Abstract][Full Text] [Related]
4. EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma.
Chen HY; Liu CH; Chang YH; Yu SL; Ho BC; Hsu CP; Yang TY; Chen KC; Hsu KH; Tseng JS; Hsia JY; Chuang CY; Chang CS; Li YC; Li KC; Chang GC; Yang PC
Oncotarget; 2016 Feb; 7(8):9017-25. PubMed ID: 26824984
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status.
Torregrosa D; Bolufer P; Lluch A; López JA; Barragán E; Ruiz A; Guillem V; Munárriz B; García Conde J
Clin Chim Acta; 1997 Jun; 262(1-2):99-119. PubMed ID: 9204213
[TBL] [Abstract][Full Text] [Related]
6. Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance.
Guérin M; Gabillot M; Mathieu MC; Travagli JP; Spielmann M; Andrieu N; Riou G
Int J Cancer; 1989 Feb; 43(2):201-8. PubMed ID: 2563719
[TBL] [Abstract][Full Text] [Related]
7. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
8. Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissues and comparison to cellular DNA content.
Brandt B; Vogt U; Harms F; Bosse U; Zänker KS; Assmann G
Gene; 1995 Jun; 159(1):29-34. PubMed ID: 7607569
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts.
Verbeek BS; Adriaansen-Slot SS; Vroom TM; Beckers T; Rijksen G
FEBS Lett; 1998 Mar; 425(1):145-50. PubMed ID: 9541025
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.
Kwak Y; Yun S; Nam SK; Seo AN; Lee KS; Shin E; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
J Transl Med; 2017 Aug; 15(1):167. PubMed ID: 28764718
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
Koutras A; Kalogeras KT; Wirtz RM; Alexopoulou Z; Bobos M; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Pentheroudakis G; Pisanidis N; Magkou C; Christodoulou C; Bafaloukos D; Papakostas P; Aravantinos G; Pectasides D; Kalofonos HP; Fountzilas G
J Transl Med; 2015 May; 13():171. PubMed ID: 26021752
[TBL] [Abstract][Full Text] [Related]
12. Gene copy numbers of HER family in breast cancer.
Zaczek A; Wełnicka-Jaśkiewicz M; Bielawski KP; Jaśkiewicz J; Badzio A; Olszewski W; Rhone P; Jassem J
J Cancer Res Clin Oncol; 2008 Feb; 134(2):271-9. PubMed ID: 17661082
[TBL] [Abstract][Full Text] [Related]
13. Classical gene amplifications in human breast cancer are not associated with distant solid metastases.
Driouch K; Champème MH; Beuzelin M; Bièche I; Lidereau R
Br J Cancer; 1997; 76(6):784-7. PubMed ID: 9310246
[TBL] [Abstract][Full Text] [Related]
14. Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
Archer SG; Eliopoulos A; Spandidos D; Barnes D; Ellis IO; Blamey RW; Nicholson RI; Robertson JF
Br J Cancer; 1995 Nov; 72(5):1259-66. PubMed ID: 7577479
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas.
Werkmeister R; Brandt B; Joos U
Oral Oncol; 2000 Jan; 36(1):100-5. PubMed ID: 10889928
[TBL] [Abstract][Full Text] [Related]
16. Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas.
al-Kasspooles M; Moore JH; Orringer MB; Beer DG
Int J Cancer; 1993 May; 54(2):213-9. PubMed ID: 8098013
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression.
Wiener JR; Kerns BJ; Harvey EL; Conaway MR; Iglehart JD; Berchuck A; Bast RC
J Natl Cancer Inst; 1994 Mar; 86(5):372-8. PubMed ID: 7905928
[TBL] [Abstract][Full Text] [Related]
18. Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.
Järvinen TA; Tanner M; Rantanen V; Bärlund M; Borg A; Grénman S; Isola J
Am J Pathol; 2000 Mar; 156(3):839-47. PubMed ID: 10702400
[TBL] [Abstract][Full Text] [Related]
19. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors.
Hudelist G; Singer CF; Manavi M; Pischinger K; Kubista E; Czerwenka K
Breast Cancer Res Treat; 2003 Aug; 80(3):353-61. PubMed ID: 14503808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
